Analysis of utilization, cost and prescription trends of mycophenolate mofetil and methotrexate among medicare patients

Analysis of utilization, cost and prescription trends of mycophenolate mofetil and methotrexate among medicare patients

Bibliographic Details
Main Authors:	Yu Wang, Joseph Jorizzo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-04-01
Series:	Journal of Dermatological Treatment
Online Access:	http://dx.doi.org/10.1080/09546634.2021.1886229

Similar Items

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
by: A. Hackl, et al.
Published: (2023-08-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
by: Swiss Medical Weekly
Published: (2009-01-01)

1602 Switching from mycophenolate mofetil to mycophenolic acid in SLE patients: Results from the RISE registry
by: Zara Izadi, et al.
Published: (2022-12-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship.
by: Rook, M, et al.
Published: (2006)

The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
by: Gan, Gin Gin, et al.
Published: (2005)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
by: Lan-Fang Li, et al.
Published: (2023-03-01)

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
by: Amit K. Reddy, et al.
Published: (2023-06-01)

Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma [version 1; peer review: 2 approved]
by: Thomas Jaki, et al.
Published: (2021-09-01)

Management of pemphigoid vegetans with mycophenolate mofetil: A case report
by: Audrey Mathieu, et al.
Published: (2024-02-01)

Post COVID‐19 organizing pneumonia treated with mycophenolate mofetil
by: Hui Xin Tan, et al.
Published: (2022-11-01)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
by: Kelly Z. Young, BA, et al.
Published: (2022-10-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
by: Yinyi Wei, et al.
Published: (2022-10-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
by: Erin B. Taylor, et al.
Published: (2017-03-01)

Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium with the Concomitant Use of Proton Pump Inhibitors in Patients who Received Kidney Transplant
by: Aysu Selçuk, et al.
Published: (2022-10-01)

Cytomegalovirus Retinitis in a Patient on Long-term Mycophenolate Mofetil Treatment for Myasthenia Gravis
by: Shyam Patel, et al.
Published: (2020-08-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Pharmacokinetics and tolerability of multiple‐day oral dosing of mycophenolate mofetil in healthy horses
by: Kaitlyn Bello, et al.
Published: (2023-09-01)

Two cases of a pharmacokinetic interaction between (val)acyclovir and mycophenolate mofetil
by: F.A. Berger, et al.
Published: (2023-01-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Utilization, cost, and prescription patterns of dupilumab among Medicare beneficiaries in the United States from 2017 to 2019
by: Michael J. Murphy, et al.
Published: (2022-11-01)

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
by: P Dalal, et al.
Published: (2010-08-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-02-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
by: Ryousuke Satou, et al.
Published: (2022-07-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)